HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Surface Modification of Liposomes Using IR700 Enables Efficient Controlled Contents Release Triggered by Near-IR Light.

Abstract
Stimuli-responsive liposomes are promising drug carriers for cancer treatment because they enable controlled drug release and the maintenance of desired drug concentrations in tumor tissue. In particular, near-IR (NIR) light is a useful stimulus for triggering drug release from liposomes based on its advantages such as deep tissue penetration and safety. Previously, we found that a silicon phthalocyanine derivative, IR700, conjugated to antibodies, can induce the rupture of the cell membrane following irradiation by NIR light. Based on this finding, we constructed IR700-modified liposomes (IR700 liposomes) and evaluated their drug release properties triggered by NIR light. IR700 liposomes released substantial amounts of encapsulated calcein following irradiation by NIR light. Drug release was substantially suppressed by the addition of sodium azide, suggesting that liposomal membrane permeabilization was mediated by singlet oxygen generated from IR700. Moreover, calcein release from IR700 liposomes triggered by NIR light was promoted under conditions of deoxygenation and the presence of electron donors. Thus, membrane disruption should be induced by the physical change of IR700 from highly hydrophilic to hydrophobic as we previously described, although singlet oxygen can cause a certain level of membrane disruption under normoxia. We also observed that doxorubicin-encapsulated IR700 liposomes exhibited significant cytotoxic effects against CT-26 murine colon carcinoma cells following NIR light exposure. These results indicate that IR700 liposomes can efficiently release anti-cancer drugs following NIR light irradiation even under hypoxic conditions and, therefore, they would be useful for cancer treatment.
AuthorsYusuke Kono, Kazuha Yokoyama, Motofumi Suzuki, Hideo Takakura, Mikako Ogawa
JournalBiological & pharmaceutical bulletin (Biol Pharm Bull) Vol. 43 Issue 4 Pg. 736-741 ( 2020) ISSN: 1347-5215 [Electronic] Japan
PMID32238716 (Publication Type: Journal Article)
Chemical References
  • Antibiotics, Antineoplastic
  • Delayed-Action Preparations
  • Drug Carriers
  • Fluoresceins
  • Indoles
  • Isoindoles
  • Liposomes
  • Photosensitizing Agents
  • liposomal doxorubicin
  • Polyethylene Glycols
  • Doxorubicin
  • fluorexon
  • phthalocyanine
Topics
  • Animals
  • Antibiotics, Antineoplastic (administration & dosage, chemistry)
  • Cell Line, Tumor
  • Cell Survival (drug effects)
  • Delayed-Action Preparations (administration & dosage, chemistry, radiation effects)
  • Doxorubicin (administration & dosage, analogs & derivatives, chemistry)
  • Drug Carriers (administration & dosage, chemistry, radiation effects)
  • Fluoresceins (administration & dosage, chemistry)
  • Humans
  • Indoles (administration & dosage, chemistry, radiation effects)
  • Isoindoles
  • Light
  • Liposomes
  • Mice
  • Photosensitizing Agents (administration & dosage, chemistry, radiation effects)
  • Polyethylene Glycols (administration & dosage, chemistry)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: